Mental health landscape in Kosova from 2017 to 2022: A retrospective study of antidepressant and anxiolytic market trends and the impact of COVID-19

IF 3.5 2区医学 Q2 PSYCHIATRY

Journal of Psychosomatic Research Pub Date : 2024-09-07 DOI:10.1016/j.jpsychores.2024.111927

{"title":"Mental health landscape in Kosova from 2017 to 2022: A retrospective study of antidepressant and anxiolytic market trends and the impact of COVID-19","authors":"","doi":"10.1016/j.jpsychores.2024.111927","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>This study explores the mental health situation in Kosova and the impact of the COVID-19 pandemic.</p></div><div><h3>Methods</h3><p>Marketed quantities of antidepressants (N06A) and anxiolytics (N05B) from 2017 to 2022 were analyzed using the Anatomical Therapeutic Chemical/Defined Daily Doses (ATC/DDD) methodology. Caution is advised as these quantities may not directly reflect patient usage and could include uses for conditions outside their primary indications.</p></div><div><h3>Results</h3><p>Prior to the pandemic, antidepressant quantities remained relatively stable, but rose from 6.8 DDD/1000 inhabitants/day in 2019 to 9.7 in 2020 and 12.4 in 2021, before returning to pre-pandemic levels of 6.8 DDD in 2022. Over 80 % of these were selective serotonin reuptake inhibitors. Meanwhile, anxiolytic quantities initially decreased from 17.4 DDD in 2017 to 9.9 in 2019, then rebounded to 17.9 DDD in 2020. Notably, alprazolam usage surged from 2.9 in 2017 to 6.9 in 2021, subsequently dropping to 2.0 in 2022.</p></div><div><h3>Conclusions</h3><p>The volatile trends in medication quantities during the pandemic suggest a fragile mental health landscape in Kosova—a developing, post-conflict country with a youthful population—underscoring the need for proactive interventions in similar contexts globally.</p></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychosomatic Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022399924003398","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

This study explores the mental health situation in Kosova and the impact of the COVID-19 pandemic.

Methods

Marketed quantities of antidepressants (N06A) and anxiolytics (N05B) from 2017 to 2022 were analyzed using the Anatomical Therapeutic Chemical/Defined Daily Doses (ATC/DDD) methodology. Caution is advised as these quantities may not directly reflect patient usage and could include uses for conditions outside their primary indications.

Results

Prior to the pandemic, antidepressant quantities remained relatively stable, but rose from 6.8 DDD/1000 inhabitants/day in 2019 to 9.7 in 2020 and 12.4 in 2021, before returning to pre-pandemic levels of 6.8 DDD in 2022. Over 80 % of these were selective serotonin reuptake inhibitors. Meanwhile, anxiolytic quantities initially decreased from 17.4 DDD in 2017 to 9.9 in 2019, then rebounded to 17.9 DDD in 2020. Notably, alprazolam usage surged from 2.9 in 2017 to 6.9 in 2021, subsequently dropping to 2.0 in 2022.

Conclusions

The volatile trends in medication quantities during the pandemic suggest a fragile mental health landscape in Kosova—a developing, post-conflict country with a youthful population—underscoring the need for proactive interventions in similar contexts globally.

查看原文本刊更多论文

2017 年至 2022 年科索沃的精神健康状况：抗抑郁药和抗焦虑药市场趋势及 COVID-19 影响的回顾性研究

本研究探讨了科索沃的精神健康状况以及 COVID-19 大流行的影响。方法使用解剖治疗化学药剂/定义日剂量（ATC/DDD）方法分析了 2017 年至 2022 年抗抑郁药（N06A）和抗焦虑药（N05B）的市场销售量。结果在大流行之前，抗抑郁药的用量保持相对稳定，但从 2019 年的 6.8 DDD/1000 居民/天上升到 2020 年的 9.7 DDD 和 2021 年的 12.4 DDD，然后在 2022 年恢复到大流行前的 6.8 DDD 水平。其中 80% 以上为选择性血清素再摄取抑制剂。与此同时，抗焦虑药的用药量最初从 2017 年的 17.4DD 降至 2019 年的 9.9DDD，随后又反弹至 2020 年的 17.9DDD。值得注意的是，阿普唑仑的使用量从 2017 年的 2.9 颗飙升至 2021 年的 6.9 颗，随后又降至 2022 年的 2.0 颗。结论大流行期间药物数量的波动趋势表明，科索沃--一个人口年轻化的冲突后发展中国家--的精神健康状况十分脆弱，这也凸显了在全球类似情况下采取积极干预措施的必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Psychosomatic Research 医学-精神病学

CiteScore

7.40

自引率

6.40%

发文量

314

审稿时长

6.2 weeks

期刊介绍： The Journal of Psychosomatic Research is a multidisciplinary research journal covering all aspects of the relationships between psychology and medicine. The scope is broad and ranges from basic human biological and psychological research to evaluations of treatment and services. Papers will normally be concerned with illness or patients rather than studies of healthy populations. Studies concerning special populations, such as the elderly and children and adolescents, are welcome. In addition to peer-reviewed original papers, the journal publishes editorials, reviews, and other papers related to the journal''s aims.

文献相关原料

公司名称	产品信息	采购帮参考价格